Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Human Genome Sciences and GSK’s Lupus Candidate Hits the Mark in Second Phase III Trial

Plan to submit marketing authorizations for Benlysta in the U.S., Europe, and other regions is on for first half of 2010.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »